Company performance
Add to research
Current Price
as of Feb 07, 2025$0.35
P/E Ratio
N/A
Market Cap
$5.37M
Description
Add to research
Organovo Holdings, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.
Metrics
Add to research
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryBiotechnology
- TickerONVO
- Price$0.3498+2.34%
Trading Information
- Market cap$5.37M
- Float97.84%
- Average Daily Volume (1m)114,505
- Average Daily Volume (3m)216,639
- EPS-$1.07
Company
- Revenue$0.10M
- Rev growth (1yr)N/A
- Net income-$2.55M
- Gross margin-133.33%
- EBITDA margin-8,463.33%
- EBITDA-$2.54M
- EV$7.54M
- EV/Revenue73.24
- P/EN/A
- P/S61.11
- P/B1.46
- Debt/Equity42.34
Documents
Add to research
SEC Filings